Status:
COMPLETED
Preoxygenation With Optiflow™ - the Effect of Speech on Lung Oxygenation.
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Conditions:
Unrecognized Condition
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
If a patient speaks during the process of preoxygenation with high-flow nasal oxygen via the Optiflow™ system, is the efficacy reduced as measured by end-tidal lung oxygen content?
Detailed Description
This is a randomised controlled trial on 34 patients undergoing routine elective surgery at the Princess Anne Hospital, Southampton. The study will take place from September 2018 to January 2019 and i...
Eligibility Criteria
Inclusion
- BMI 18-35, ASA category 1 or 2
Exclusion
- Inability to read/ follow instructions, Heavily sedated
Key Trial Info
Start Date :
October 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2018
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03766646
Start Date
October 18 2018
End Date
November 16 2018
Last Update
October 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Southampton
Southampton, Hants, United Kingdom, SO16 6YD